Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 26, 1997

View Archived Issues

Xenova: Q3 1997 highlights

SmithKline Beecham: Q3 1997 highlights

Nefadar: new antidepressant introduced in Germany

Extended-release Effexor introduced in U.S. for depression

rhBMP-2 efficacy in dental reconstruction demonstrated

Scios and DuPont Merck collaborate on Alzheimer's disease research

Positive phase I/II results reported for adenoviral p53 gene therapy

Synergistic antihypertensive activity of Ang II antagonist/ACE inhibitor combination in SHR

Results from Leuvectin trial in kidney cancer patients reported

Preliminary results reported for IL-2 gene therapy in GI cancer

NINDS study links herpesvirus strain to MS

ImmuLogic restructures its operations

Sertoli and Carolinas Medical Center collaborate to develop novel diabetes therapy

ProLease hGH slated to enter phase III

Milestone reached in antiinfectives alliance

New agents for heart disease prepared by Dainippon Ink & Chemicals

Roussel Uclaf discloses integrin antagonists for bone disorders

Takeda develops potassium channel openers for cardiovascular indications

PTK inhibitors for bone disorders from Novartis

Arzneimittelwerk Dresden prepares new 5-LO inhibitors

JT licenses new oral antiinflammatory agent to R.W. Johnson

NDA filed in U.S. for Otsuka antiplatelet agent

First marketing approval granted for Neumega

Subset of stroke patients shows neurological improvement after phenylephrine-induced hypertension

Expanded use approved for ReoPro in Europe

Cardiotoxicity of SM-5887 and doxorubicin compared in rabbits

Fedotozine efficacy in functional dyspepsia established

Preclinical pharmacokinetics, antitumor activity and toxicity of CI-994

Electroporation for gene delivery into tumor cells: in vivo results

Forest files for FDA approval of Synapton

Fujirebio, Nippon Chemiphar to codevelop antiasthma drug

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...